{"DataElement":{"publicId":"7366083","version":"1","preferredName":"Sulfonylurea Antidiabetic Agent Receive Yes No Does Not Know Indicator","preferredDefinition":"The yes/no/does not know indicator as to whether the patient received sulfonylurea antidiabetic agent.","longName":"7366082v1.0:3270332v1.0","context":"Alliance","contextVersion":"1","DataElementConcept":{"publicId":"7366082","version":"1","preferredName":"Sulfonylurea Antidiabetic Agent Receive","preferredDefinition":"Sulfonamide urea derivatives with antihyperglycemic activity. Sulphonylurea antidiabetic agents bind to sulfonylurea receptor type 1 (SUR1), the subunit of ATP-sensitive inwardly-rectifier potassium (IKATP) channels on the membranes of pancreatic beta cells, thereby blocking the inward current flow (influx) of positively charged K+ ions into the cell. This results in tonic membrane depolarization, and induces a calcium ion influx through voltage-sensitive calcium channels; increased intracellular calcium ion levels trigger exocytosis of insulin-containing granules. This eventually induces secretion of insulin. The IKATP channels found in pancreatic islets are complexes of four IKATP 6.2 and four SUR1 subunits. In addition, some sulfonylureas of larger molecular size may increase the sensitivity of peripheral tissues to insulin mediated through peroxisome proliferator-activated receptor gamma (PPARgamma)._To take, accept, or get something offered.","longName":"7366080v1.0:2184327v1.0","context":"Alliance","contextVersion":"1","ObjectClass":{"publicId":"7366080","version":"1","preferredName":"Sulfonylurea Antidiabetic Agent","preferredDefinition":"Sulfonamide urea derivatives with antihyperglycemic activity. Sulphonylurea antidiabetic agents bind to sulfonylurea receptor type 1 (SUR1), the subunit of ATP-sensitive inwardly-rectifier potassium (IKATP) channels on the membranes of pancreatic beta cells, thereby blocking the inward current flow (influx) of positively charged K+ ions into the cell. This results in tonic membrane depolarization, and induces a calcium ion influx through voltage-sensitive calcium channels; increased intracellular calcium ion levels trigger exocytosis of insulin-containing granules. This eventually induces secretion of insulin. The IKATP channels found in pancreatic islets are complexes of four IKATP 6.2 and four SUR1 subunits. In addition, some sulfonylureas of larger molecular size may increase the sensitivity of peripheral tissues to insulin mediated through peroxisome proliferator-activated receptor gamma (PPARgamma).","longName":"C97936","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sulfonylurea Antidiabetic Agent","conceptCode":"C97936","definition":"Sulfonamide urea derivatives with antihyperglycemic activity. Sulphonylurea antidiabetic agents bind to sulfonylurea receptor type 1 (SUR1), the subunit of ATP-sensitive inwardly-rectifier potassium (IKATP) channels on the membranes of pancreatic beta cells, thereby blocking the inward current flow (influx) of positively charged K+ ions into the cell. This results in tonic membrane depolarization, and induces a calcium ion influx through voltage-sensitive calcium channels; increased intracellular calcium ion levels trigger exocytosis of insulin-containing granules. This eventually induces secretion of insulin. The IKATP channels found in pancreatic islets are complexes of four IKATP 6.2 and four SUR1 subunits. In addition, some sulfonylureas of larger molecular size may increase the sensitivity of peripheral tissues to insulin mediated through peroxisome proliferator-activated receptor gamma (PPARgamma).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB1085F7-5D39-0957-E053-4EBD850A5C36","latestVersionIndicator":"Yes","beginDate":"2020-07-23","endDate":null,"createdBy":"MORENOC","dateCreated":"2020-07-23","modifiedBy":"ONEDATA","dateModified":"2020-07-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2184327","version":"1","preferredName":"Received","preferredDefinition":"Received; taken, gotten, or acquired.","longName":"Received","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Receive","conceptCode":"C25639","definition":"To take, accept, or get something offered.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB6C8AC6-1F66-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB1085F7-5D47-0957-E053-4EBD850A5C36","latestVersionIndicator":"Yes","beginDate":"2020-07-23","endDate":null,"createdBy":"MORENOC","dateCreated":"2020-07-23","modifiedBy":"MORENOC","dateModified":"2020-10-20","changeDescription":"10/20/2020: CM Released as part of draft content review","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3270332","version":"1","preferredName":"Yes No Does Not Know Indicator","preferredDefinition":"The affirmative response to a question or activity._The non-affirmative response to a question._The answer is not known by the person answering._An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","longName":"3270332v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"10","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Don't know","valueDescription":"Don't Know/Refused","ValueMeaning":{"publicId":"2654058","version":"1","preferredName":"Don't Know/Refused","longName":"2654058","preferredDefinition":"The answer is not known by the person answering.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Does Not Know","conceptCode":"C67142","definition":"The answer is not known by the person answering.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"32BD33B1-0E11-3D3A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-12","endDate":null,"createdBy":"UMLLOADER_TOBACCO","dateCreated":"2007-06-12","modifiedBy":"TSESU","dateModified":"2023-03-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AC6190CA-F659-268C-E040-BB89AD432A45","beginDate":"2011-09-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-09-07","modifiedBy":"ONEDATA","dateModified":"2011-09-07","deletedIndicator":"No"},{"value":"No","valueDescription":"No","ValueMeaning":{"publicId":"2559515","version":"1","preferredName":"No","longName":"2559515","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B588-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"GDEEN","dateModified":"2024-01-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AC6190CA-F663-268C-E040-BB89AD432A45","beginDate":"2011-09-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-09-07","modifiedBy":"ONEDATA","dateModified":"2011-09-07","deletedIndicator":"No"},{"value":"Yes","valueDescription":"Yes","ValueMeaning":{"publicId":"2560453","version":"1","preferredName":"Yes","longName":"2560453","preferredDefinition":"The affirmative response to a question or activity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B932-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"CLOHNES","dateModified":"2023-09-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AC6190CA-F66D-268C-E040-BB89AD432A45","beginDate":"2011-09-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-09-07","modifiedBy":"ONEDATA","dateModified":"2011-09-07","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3270331","version":"1","preferredName":"Yes No Does Not Know Indicator","preferredDefinition":"The affirmative response to a question or activity.:The non-affirmative response to a question.:The answer is not known by the person answering.:An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","longName":"C49488:C49487:C67142:C25180","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Does Not Know","conceptCode":"C67142","definition":"The answer is not known by the person answering.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Indicator","conceptCode":"C25180","definition":"An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AC6190CA-F632-268C-E040-BB89AD432A45","latestVersionIndicator":"Yes","beginDate":"2011-09-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-09-07","modifiedBy":"ONEDATA","dateModified":"2011-09-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AC6190CA-F643-268C-E040-BB89AD432A45","latestVersionIndicator":"Yes","beginDate":"2011-09-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-09-07","modifiedBy":"PWEST","dateModified":"2015-11-02","changeDescription":"Released per approval by S.Shakour. mc 9/21/11","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Sulfonylureas","type":"Preferred Question Text","description":"Sulfonylureas","url":null,"context":"Alliance"}],"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB1D0D86-588D-7441-E053-4EBD850AB702","latestVersionIndicator":"Yes","beginDate":"2020-07-23","endDate":null,"createdBy":"MORENOC","dateCreated":"2020-07-23","modifiedBy":"MORENOC","dateModified":"2020-10-22","changeDescription":"10/22/2020: CM Released as part of draft content review","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}